Prices delayed by at least 15 minutes | Print
Haleon PLC (HLN)
ORD GBP0.01This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
IN BRIEF: Haleon acquires remaining 12% stake in Chinese joint venture
Haleon PLC - Weybridge, Surrey-based consumer healthcare firm that spun out of GSK PLC in 2022 - Agrees to acquire the remaining 12% stake in Tianjin TSKF Pharmaceutical Co Ltd, its joint venture in China, following its acquisition of a further 33% interest in December 2024. The remaining stake will be bought from partner Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd for a total of CNY1.62 billion, around USD221 million. TSKF will become a wholly-owned subsidiary of Haleon.
The purchase will be funded via Haleon's existing cash resources and new local-currency debt and is expected to close within the next three months, it said.
Current stock price: 379.40 pence, up 0.1% in London on Tuesday morning
12-month change: up 17%
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2025 Alliance News Ltd. All Rights Reserved.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.